Moreover, CDKL3 was considered as a therapeutic target of curcumol, a major component extracted from the root of Rhizoma Curcumae, mediating the anticancer effects in cholangiocarcinoma cells [22]. This evidence concerns the gene CDKL3 and cholangiocarcinoma.